Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators
Lucía Pérez-Regidor, Malik Zarioh, Laura G. Ortega, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1508-1508
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
N. N. Kuz’mich, К. В. Сивак, Vladimir N. Chubarev, et al.
Vaccines (2017) Vol. 5, Iss. 4, pp. 34-34
Open Access | Times Cited: 531
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
Victor T. Sabe, Thandokuhle Ntombela, Lindiwe A. Jhamba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113705-113705
Closed Access | Times Cited: 453
Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2
Shafi Mahmud, Mohammad Abu Raihan Uddin, Gobindo Kumar Paul, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1402-1414
Open Access | Times Cited: 96
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
Sonya VanPatten, Yousef Al‐Abed
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 12, pp. 5093-5107
Open Access | Times Cited: 92
Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 131-131
Open Access | Times Cited: 30
Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
Chandrabose Selvaraj, Umesh Panwar, Dhurvas Chandrasekaran Dinesh, et al.
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 49
Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”
Carmela Rita Balistreri, Giovanni Ruvolo, Domenico Lio, et al.
Journal of Molecular and Cellular Cardiology (2017) Vol. 110, pp. 38-53
Open Access | Times Cited: 54
Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators
Manuela S. Murgueitio, Christin Rakers, Anne Frank, et al.
Trends in Pharmacological Sciences (2016) Vol. 38, Iss. 2, pp. 155-168
Closed Access | Times Cited: 34
Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
Vinita Mishra, Chandramani Pathak
International Journal of Biological Macromolecules (2018) Vol. 122, pp. 425-451
Closed Access | Times Cited: 34
Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods
Maria Bzówka, Weronika Bagrowska, Artur Góra
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 12, pp. 3669-3687
Open Access | Times Cited: 11
Exploring the role of microbial proteins in controlling environmental pollutants based on molecular simulation
Jieting Wu, Jin Lv, Lei Zhao, et al.
The Science of The Total Environment (2023) Vol. 905, pp. 167028-167028
Closed Access | Times Cited: 10
Enhanced in silico QSAR-based screening of butyrylcholinesterase inhibitors using multi-feature selection and machine learning
D. Sharmistha, M Prabha, Ravi Kiran, et al.
SAR and QSAR in environmental research (2025), pp. 1-21
Closed Access
Development and Testing of Druglike Screening Libraries
Junmei Wang, Yubin Ge, Xiang‐Qun Xie
Journal of Chemical Information and Modeling (2018) Vol. 59, Iss. 1, pp. 53-65
Open Access | Times Cited: 32
OptiPharm: An evolutionary algorithm to compare shape similarity
Savíns Puertas-Martín, Juana L. Redondo, Pilar M. Ortigosa, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 21
An update on endotoxin neutralization strategies in Gram-negative bacterial infections
Klaus Brandenburg, Andra B. Schromm, Günther Weindl, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 4, pp. 495-517
Closed Access | Times Cited: 19
Comprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets
Nilofer Shaikh, R. K Linthoi, K. Venkateswara Swamy, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7735-7743
Closed Access | Times Cited: 12
Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer
Mohan Anbuselvam, Sneha Krishnamoorthy, Rajalakshmi Sabanayagam, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175961-175961
Closed Access | Times Cited: 7
Identification of potential Aurora kinase-C protein inhibitors: an amalgamation of energy minimization, virtual screening, prime MMGBSA and AutoDock
Revanth Bathula, Goverdhan Lanka, Narasimha Muddagoni, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 8, pp. 2314-2325
Closed Access | Times Cited: 18
Small Molecules as Toll-like Receptor 4 Modulators Drug and In-House Computational Repurposing
Lucía Pérez-Regidor, Joan Guzman‐Caldentey, Nils Oberhauser, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2326-2326
Open Access | Times Cited: 11
Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB
Yan Tuo, Yuelu Tang, Ran Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126109-126109
Closed Access | Times Cited: 6
Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors
Gera Narendra, Baddipadige Raju, Himanshu Verma, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 107, pp. 107950-107950
Closed Access | Times Cited: 14
Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an e-Pharmacophore-Based Approach
Rohini Karunakaran, Pratika Agarwal, B. Preethi, et al.
Applied Biochemistry and Biotechnology (2018) Vol. 187, Iss. 1, pp. 194-210
Closed Access | Times Cited: 15
RETRACTED: Overcoming antibiotic resistance: Is siderophore trojan horse conjugation an answer to evolving resistance in microbial pathogens?
Kalyani Dhusia, Archana Bajpai, Pramod W. Ramteke
Journal of Controlled Release (2017) Vol. 269, pp. 63-87
Closed Access | Times Cited: 14
Identification of inhibitors of the E. coli chaperone SurA using in silico and in vitro techniques
Eric W. Bell, Erica J. Zheng, Lisa M. Ryno
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 22, pp. 3540-3548
Closed Access | Times Cited: 12
FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy.
Hakimeh Zali, Ali Golchin, Masoumeh Farahani, et al.
PubMed (2019) Vol. 18, Iss. 3, pp. 1639-1647
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top